FDA
-
-
-
-
-
-
-
Acadia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Trofinetide for the Treatment of Rett Syndrome
-
-
-
-
-
-
-
ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results
-
-
-
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

